We therefore designed the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) trial to compare the efficacy and safety of the early and long-term ...

The CURE trial is a large international study to determine if acute and long-term treatment with the combination of clopidogrel and aspirin is superior to ...

A landmark clinical trial at UC Davis Health, known formally as the “CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele," is now underway.

3 дек. 2017 г. · CURE was designed to evaluate if clopidogrel would further improve outcomes from ACS when added to ASA. The Clopidogrel in Unstable Angina to ...

22 сент. 2014 г. · In the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial (CURE), investigators evaluated the effects of clopidogrel in ...

The antiplatelet drug clopidogrel (Plavix) decreased the rate of the combined end point of cardiovascular death, nonfatal myocardial infarction, or stroke by ...

12 янв. 2018 г. · Initially study included patients >60 years of age with history of coronary artery disease and no new ECG changes; After enrolment of 3000 ...

1 янв. 2018 г. · The results of the CURE study do not provide evidence that routine use of clopidogrel in addition to conventional therapy including aspirin is warranted.

PCI-CURE was a prospectively designed study of patients undergoing PCI who were randomised to double-blind therapy with clopidogrel or placebo in the ...

The CURE trial is a large international study to determine if acute and long-term treatment with the combination of clopidogrel and aspirin is superior to ...